RITTER PHARMACEUTICALS INC (RTTR)
Institutional ownership reported to the SEC as of Q1 2020, across 6 quarters.
10
Reporting holders
$1.2M
Reported value
94.7%
Held as options
+2
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Alyeska Investment Group, L.P. | $1.1M | options only | 0.02% | 6q | OPTIONS |
| VANGUARD GROUP INC | $24.0K | 91,096 | 0.00% | 6q | HELD |
| CITADEL ADVISORS LLC | $14.0K | 53,925 | 0.00% | new | NEW |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $7.0K | 25,026 | 0.00% | new | NEW |
| BlackRock Inc. | $4.0K | 15,081 | 0.00% | 6q | +8.2% |
| TWO SIGMA SECURITIES, LLC | $4.0K | 16,296 | 0.00% | 2q | -49.2%-$3.9K |
| UBS Group AG | $4.0K | 13,848 | 0.00% | 2q | -70.0%-$9.3K |
| MORGAN STANLEY | $3.0K | 12,000 | 0.00% | new | NEW |
| VICTORY CAPITAL MANAGEMENT INC | $2.0K | 8,648 | 0.00% | new | NEW |
| AdvisorNet Financial, Inc | $1.0K | 4,000 | 0.00% | new | NEW |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q1 2020 | 10 | $1.2M | 239,920 | 5 | 1 | 2 | 94.7% |
| Q4 2019 | 8 | $832.0K | 683,691 | 3 | 3 | 1 | 86.3% |
| Q3 2019 | 7 | $1.6M | 783,275 | 1 | 3 | 0 | 84.5% |
| Q2 2019 | 11 | $5.2M | 620,387 | 1 | 3 | 2 | 87.3% |
| Q1 2019 | 12 | $4.2M | 572,082 | 3 | 3 | 1 | 88.1% |
| Q4 2018 | 11 | $3.0M | 792,676 | 1 | 0 | 0 | 84.3% |